WE NOW HAVE DEDICATED FACILITIES FOR THE MANUFACTURE OF PHARMACEUTICAL COAL TAR
Iodoform compound paint BP (Whitehead’s varnish).
GMP Pharma has positioned itself as a specialist supplier of Whitehead's Varnish (Iodoform compound paint BP). We welcome enquiries for a DMF/ASMF.
Iodoform compound paint BP is a solution containing iodoform, a yellowish crystalline substance with antiseptic properties, dissolved in Ether and mixed with other resinous compounds to form a varnish-like substance.
The bulk supply of iodoform compound paint BP, or Whitehead's varnish, involves a meticulous process encompassing procurement, manufacturing, quality control, packaging, distribution, and regulatory compliance. This ensures the availability of a high-quality product that meets the needs of various industries, including healthcare and pharmaceuticals.
Bulk supply of Iodoform compound paint BP, commonly known as Whitehead's varnish, entails the procurement, manufacturing, packaging, and distribution of this specialised compound on a large scale.
Procurement of Raw Materials: The bulk supply process begins with sourcing the necessary raw materials. This typically includes iodoform, alcohol, and other additives or solvents required for the formulation. These materials are obtained from reliable suppliers ensuring high quality and purity standards.
Manufacturing Process: The manufacturing process of Whitehead's varnish involves precise formulation and mixing of the raw materials in controlled conditions. The iodoform is dissolved in alcohol, and any additional components are added according to the specific formulation requirements. This process may be conducted in specialized chemical plants equipped with the necessary equipment for mixing, heating, and cooling.
Quality Control: Quality control is a critical aspect of bulk production to ensure consistency and adherence to regulatory standards. Samples from each batch are subjected to rigorous testing for purity, potency, and safety. This ensures that the final product meets the specifications outlined in the British Pharmacopoeia (BP) or other relevant regulatory guidelines.
Packaging: Once the iodoform compound paint BP is manufactured and tested, it is ready for packaging. Bulk quantities are typically packaged in containers such as drums, barrels, or intermediate bulk containers (IBCs) to facilitate handling and transportation. Proper labelling with essential information such as product name, batch number, expiration date, and safety warnings is also applied to each package.
Regulatory Compliance: Throughout the entire supply chain process, adherence to regulatory requirements is paramount. This includes compliance with relevant health and safety regulations, as well as adherence to good manufacturing practices (GMP) and other quality standards. Regular inspections by regulatory authorities are conducted to verify compliance.